| Shelby Cain, CRNA | |
|
2655 Northwinds Pkwy, Alpharetta, GA 30009-2280 | |
| (678) 690-8332 | |
| Not Available |
| Full Name | Shelby Cain |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | 2655 Northwinds Pkwy, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962947572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 118059 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthomed Staffing Llc | 9638429178 | 237 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Spine Team Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629082995 PECOS PAC ID: 6507888757 Enrollment ID: O20051230000616 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Premier Anesthesia Of Huntsville A Division Of Premier Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346570355 PECOS PAC ID: 7012045685 Enrollment ID: O20100503000712 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Texoma Anesthesia P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063798148 PECOS PAC ID: 1759558547 Enrollment ID: O20120119000162 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Valiant Anesthesia Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588906812 PECOS PAC ID: 5092956243 Enrollment ID: O20130730000861 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Orthomed Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225514276 PECOS PAC ID: 9638429178 Enrollment ID: O20180905000794 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Rpm Anesthesia, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669022786 PECOS PAC ID: 6901238443 Enrollment ID: O20191121000648 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Synergy Anesthesia Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780251595 PECOS PAC ID: 6406252246 Enrollment ID: O20210902002074 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Entity Name | Dfw Oba Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124468855 PECOS PAC ID: 0941684963 Enrollment ID: O20220825000395 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelby Cain, CRNA 2655 Northwinds Pkwy, Alpharetta, GA 30009-2280 Ph: (678) 690-8332 | Shelby Cain, CRNA 2655 Northwinds Pkwy, Alpharetta, GA 30009-2280 Ph: (678) 690-8332 |
News Archive
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported profitable financial results for its fourth fiscal quarter ended March 31, 2011.
Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.
Maryland health officials plan to release today their newest plan to control cancer, a set of diseases responsible for one in four deaths in the state. The officials say the plan to be used by health care providers, policy makers, communities and individuals is ambitious, aiming to save some 1,200 more people a year. Now, about 10,000 Marylander die a year from all kinds of cancer.
› Verified 8 days ago
Rae Wood Grimsley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Joshua A Getzinger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Shelby Pope, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Monica E Burrell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3333 Old Milton Pkwy, Alpharetta, GA 30005 Phone: 770-645-9181 Fax: 770-645-8455 | |
Tyrena Burroughs, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Roviena J Royulada-ycu, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-643-5619 | |
Montez Charmara Badger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2655 Northwinds Pkwy, Alpharetta, GA 30009 Phone: 770-522-1890 |